Showing 601 - 620 results of 151,125 for search '(( a we decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.66s Refine Results
  1. 601
  2. 602
  3. 603

    Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions... by Nathan P Gillett (557010)

    Published 2013
    “…<p><strong>Figure 1.</strong> Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions [<a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib1" target="_blank">1</a>, <a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib10" target="_blank">10</a>, <a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib11" target="_blank">11</a>]. …”
  4. 604
  5. 605
  6. 606

    A PPARα Promoter Variant Impairs ERR-Dependent Transactivation and Decreases Mortality after Acute Coronary Ischemia in Patients with Diabetes by Sharon Cresci (53599)

    Published 2010
    “…Consistent with previous descriptions of PPARα in experimental models and human disease, we describe a novel <em>PPARA</em> promoter SNP that decreases transcriptional activation of <em>PPARA</em> and protects against mortality in diabetic patients after ACS.…”
  7. 607
  8. 608
  9. 609
  10. 610

    Image_2_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

    Published 2022
    “…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”
  11. 611

    Image_1_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

    Published 2022
    “…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”
  12. 612

    Image_3_Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.PDF by Nicole C. McCoy (12459036)

    Published 2022
    “…The implementation group showed significantly reduced median intraoperative (20.0 mg vs. 0.0 mg; p < 0.001) and total opioid consumption (20.5 mg vs. 0.0 mg; p < 0.001). The number of patients who received any opioids decreased from 84.2% (16/19) before implementation to 23.1% (3/13) after implementation.…”
  13. 613
  14. 614
  15. 615
  16. 616
  17. 617
  18. 618

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  19. 619

    A sample choice question without a warning label. by Yulian Ding (5984591)

    Published 2024
    “…We draw a sample of 1200 participants from five major cities across China to analyze the warning label’s effectiveness in reducing urban consumers’ purchases of SSBs, with a particular emphasis on how an individual’s habit strength affects their reaction to the warning label. …”
  20. 620

    Zileuton, 5-Lipoxygenase Inhibitor, Acts as a Chemopreventive Agent in Intestinal Polyposis, by Modulating Polyp and Systemic Inflammation by Elias Gounaris (52393)

    Published 2015
    “…Here we report that Zileuton, a specific 5-LO inhibitor, can prevent polyp formation by efficiently reducing the tumor-associated and systemic inflammation in APC<sup>Δ468</sup> mice.…”